Journal of Cannabis Research  An open source, peer reviewed, multidisciplinary, international journal sponsored by the Institute of Cannabis Research at Colorado State University - Pueblo.  Articles focus on all matter cannabis, including agriculture and plant biology; commerce, business, and environment; the endocannabinoid system; pharmacology, biochemistry, and cannabinoid genetics; epidemiology and public health; medical cannabis; and history, regulations, and public policy.

“CBD demonstrates activity against gram-positive bacteria” — As antibiotic resistance to common bacterial infections grows worldwide, there is an urgent need to develop novel therapies for fighting drug-resistant bacteria. Promising results from a study conducted at the University of Queensland’s Institute for Molecular Bioscience’s Center for Superbug Solutions show CBD is effective at combating drug-resistant bacterial strains like Staphyloccocus aureus (including MRSA), Streptococcus pneumonia, and Enterococcus faecalis.

CBD to treat hypoxic-ischemic encephalopathy in newborns — Hypoxic-ischemic encephalopathy (HIE) is the leading cause of infant fatalities in the U.S. and a primary source of severe neurological impairments, according to Brain Injury Guide. Pre-clinical studies show combination therapy of hypothermia (the gold standard of care for HIE) and cannabidiol lead to better outcomes, and have paved the way to clinical trials in newborns in the U.K. and Spain.

“CBD reduces craving and anxiety in people with heroin use disorder” — Findings from a study at the Icahn School of Medicine at Mount Sinai

"Israeli researchers probe how cannabis can treat endometriosis"— Anecdotal evidence indicates cannabis use provides relief from the painful symptoms of endometriosis. Israeli researchers are investigating various cannabis compounds to treat a condition that affects an estimated 176 million women worldwide.

“Safety and Efficacy of Medical Cannabis in Fibromyalgia” — An observational study of fibromyalgia patients in Israel concludes medical cannabis is a safe and effective therapeutic option for fibromyalgia symptoms when treatment compounds and regimen are standardized. Authors highlight the need for double-blind, placebo-controlled, randomized trials to better understand the role cannabis can play in fibromyalgia treatment.

Iraq and Afghanistan Veterans of America, Member Survey — IAVA's 2019 Member Survey illustrates overwhelming support of medical cannabis and medical cannabis research by veterans and active duty members.  A few takeaways: 83% support legalizing medical cannabis, 90% support medical cannabis research, 20% use cannabis medicinally, and 91% would opt for medical cannabis or cannabinoid therapy if these treatment options were available to them.

The American Legion, Veteran Household Survey — The Legion's 2017 survey of veterans, their families, and caregivers.  Across age range, gender, politics, branch of service, and geographic location, veteran households support medical cannabis use and research. In short, 82% support legalizing medical cannabis, 92% support medical cannabis research, and 22% (of veterans) use cannabis to treat a medical condition.

The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research  The National Academies of Sciences, Engineering, and Medicine's 2017 comprehensive analysis of the health effects of cannabis and cannabinoid use for medical and recreational purposes, their recommendations for further study, and a call for "funding and supporting a national cannabis research agenda".